Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-26

FDA Approved: THEOPHYLLINE — Original Application (Bionpharma Inc.,)

View source ↗

Summary

FDA approves Bionpharma Inc.’s Theophylline generic under an Original Application (ANDA). The product is approved for use in asthma and chronic obstructive pulm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

ORIG AP for THEOPHYLLINE (THEOPHYLLINE)